Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine vs Dosulepin in Somatic Symptom Disorder
NCT06803485Phase 4Recruiting
- Sponsor
- AIIMS New Delhi
- Start
- Mar 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of venlafaxine in somatic symptom disorder (SSD), sponsored by AIIMS New Delhi. Started Mar 2025; status: recruiting.
02
Drugs
venlafaxine
03
Conditions
somatic symptom disorder (SSD)
Beyond the preview
Go deeper on NCT06803485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06803485.